{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:07:10Z","timestamp":1794506830740,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.seizure.2024.01.010","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:44:04Z","timestamp":1705549444000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Purified cannabidiol as add-on therapy in children with treatment-resistant infantile epileptic spasms syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"Gabriela","family":"Reyes Valenzuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-2152","authenticated-orcid":false,"given":"Adolfo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Fasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Galicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Adi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Sebastian","family":"Fortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caraballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.seizure.2024.01.010_bib0001","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on nosology and definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2024.01.010_bib0002","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.seizure.2024.01.010_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1528-1167.2006.00689.x","article-title":"Cognitive and behavioral outcome in West syndrome","volume":"47","author":"Guzzetta","year":"2006","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2024.01.010_bib0004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1535-7511.2006.00100.x","article-title":"Infantile spasms: little seizures, BIG consequences","volume":"6","author":"Shields","year":"2006","journal-title":"Epilepsy Curr"},{"issue":"Suppl Suppl 2","key":"10.1016\/j.seizure.2024.01.010_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/epi4.12264","article-title":"Treatment of infantile spasms","volume":"3","author":"Hussain","year":"2018","journal-title":"Epilepsia Open"},{"issue":"21","key":"10.1016\/j.seizure.2024.01.010_bib0006","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Cannabidiol in Dravet Syndrome Study Group. Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2024.01.010_bib0007","first-page":"1888","article-title":"GWPCARE3 Study Group. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018"},{"issue":"2","key":"10.1016\/j.seizure.2024.01.010_bib0008","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: an open-label extension trial","volume":"63","author":"Thiele","year":"2022","journal-title":"Epilepsia"},{"issue":"10125","key":"10.1016\/j.seizure.2024.01.010_bib0009","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"GWPCARE4 Study Group. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2024.01.010_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.05.013","article-title":"Open-label use of highly purified CBD (Epidiolex\u00ae) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes","volume":"86","author":"Devinsky","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.seizure.2024.01.010_bib0011","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/epi.14477","article-title":"CBD EAP study group. Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: expanded access program results","volume":"59","author":"Szaflarski","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2024.01.010_bib0012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","article-title":"Highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond dravet syndrome and lennox-gastaut syndrome","volume":"35","author":"Lattanzi","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2024.01.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109245","article-title":"Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures","volume":"143","author":"Caraballo","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2024.01.010_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.seizure.2022.01.001","article-title":"Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy","volume":"95","author":"Caraballo","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.01.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106826","article-title":"Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: a multicenter phase-2 study","volume":"102","author":"Hussain","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2024.01.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106988","article-title":"Cannabidiol in treatment of refractory epileptic spasms: an open-label study","volume":"106","author":"Herlopian","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.seizure.2024.01.010_bib0017","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/epi.17665","article-title":"Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the expanded access program","volume":"64","author":"Flamini","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.01.010_bib0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.seizure.2021.10.002","article-title":"Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: a study of eight patients","volume":"92","author":"Caraballo","year":"2021","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2024.01.010_bib0019","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.010_bib0020","doi-asserted-by":"crossref","first-page":"e0004","DOI":"10.5041\/RMMJ.10387","article-title":"Medical cannabis for intractable epilepsy in childhood: a review","volume":"11","author":"Ben-Zeev","year":"2020","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.seizure.2024.01.010_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106446","article-title":"Electroclinical pattern in the transition from West to Lennox-Gastaut syndrome","volume":"167","author":"Calvo","year":"2020","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.seizure.2024.01.010_bib0022","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/epi4.12699","article-title":"Real-world data on cannabidiol treatment of various epilepsy subtypes: a retrospective, multicenter study","volume":"8","author":"K\u00fchne","year":"2023","journal-title":"Epilepsia Open"},{"issue":"151","key":"10.1016\/j.seizure.2024.01.010_bib0023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.33588\/rn.26151.98953","article-title":"S\u00edndrome de West sintom\u00e1tico: asociaciones etiol\u00f3gicas particulares con respuesta inesperada al tratamiento [Symptomatic West's syndrome: specific etiological link to unexpected response to treatment]","volume":"26","author":"Caraballo","year":"1998","journal-title":"Rev Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2024.01.010_bib0024","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/dmcn.15153","article-title":"Irish Paediatric Neurology Group. Response to treatment and outcomes of infantile spasms in Down syndrome","volume":"64","author":"Harvey","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2024.01.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106663","article-title":"Spontaneous remission of West syndrome associated with acute infection and fever in five patients","volume":"174","author":"Caraballo","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2024.01.010_bib0026","first-page":"1","article-title":"Cannabidiol use patterns and efficacy for children who have cerebral palsy","author":"Seltzer","year":"2023","journal-title":"Orthopedics"},{"issue":"9","key":"10.1016\/j.seizure.2024.01.010_bib0027","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0883073818773028","article-title":"Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders","volume":"33","author":"Libzon","year":"2018","journal-title":"J Child Neurol"},{"issue":"9","key":"10.1016\/j.seizure.2024.01.010_bib0028","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/dmcn.14548","article-title":"Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial","volume":"62","author":"Fairhurst","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"17","key":"10.1016\/j.seizure.2024.01.010_bib0029","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","article-title":"Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis","volume":"78","author":"Lattanzi","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.010_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/14737175.2021.1834383","article-title":"Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome","volume":"21","author":"Lattanzi","year":"2021","journal-title":"Expert Rev Neurother"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T03:11:24Z","timestamp":1738465884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"alternative-id":["S1059131124000189"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.01.010","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purified cannabidiol as add-on therapy in children with treatment-resistant infantile epileptic spasms syndrome","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}